Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

By J. Panyam, V. Labhasetwar. Advanced Drug Delivery Reviews, 2003

3,323 citations recorded by the source corpus.

Subfields: Biomaterials, Molecular Biology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/e0fd7c2e06133fad223a47006a34d4b435a607d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. F. Danhier
2. J. Hanes
3. K. O’Connor
4. Mohamed Al-Fandi
5. K. Divya
6. P. Couvreur
7. T. Yih
8. R. Seeram

In Molecular Biology

1. F. Danhier
2. J. Hanes
3. Y. Chisti
4. P. Couvreur
5. Mohamed Al-Fandi
6. K. Divya
7. T. Yih
8. Ying-Ying Wang

In Pharmaceutical Science

1. J. Hanes
2. Ying-Ying Wang
3. S. Lai
4. Mohamed Al-Fandi
5. K. Divya
6. P. Couvreur
7. T. Yih
8. V. Préat

Citations in the corpus

• Beneficial role of carbon nanotubes on mustard plant growth: an agricultural prospect (2011, neutral): “(Harrison and Atala 2007; Panyam and Labhasetwar 2003; Zanello et al. 2006).”
• PCL and PCL-based materials in biomedical applications (2018, background): “For an effective drug delivery system it is very important to deliver the therapeutic molecules selectively or preferentially to the target site at the desired dose for predetermined period [33].”
• Hydrogel nanoparticles in drug delivery. (2008, background): “In recent years, significant efforts have been devoted to use the potentials of nanotechnology in drug delivery since it offers a suitable means of site-specific and/or time-controlled delivery of small or large molecular weight drugs and other bioactive agents [1–9].”
• Current progress on bio-based polymers and their future trends (2013, background): “…et al. 1999; Sodian et al. 1999, 2000; Cheng et al. 2009 PLA/chitosan PLA/PLGA/ chitosan PLA Drug carrier/drug release Jeevitha and Kanchana 2013; Jayanth and Vinod 2012; Nagarwal et al. 2010; Chandy et al. 2000; Valantin et al. 2003 PLGA and copolymers Degradable sutures Rajev 2000 PLA/HA…”
• DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. (2008, background): “More importantly is the potential for the application of Ag NPs in the treatment of diseases that need constant drug concentration in the blood or targeting of specific cells or organs (Moghimi et al., 2001; Panyam and Labhasetwar, 2003).”
• Nanoparticle-based targeted drug delivery (2009, background): “In general, the nanosize of these particles allows for efficient uptake by a variety of cell types and selective drug accumulation at target sites (Desai et al., 1997; Panyam and Labhasetwar, 2003; Panyam et al., 2003b).”
• Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy (2007, background): “Conclusion In the course of the past decade, the field of drug delivery has been revolutionized with the advent of nanotechnology, wherein biocompatible nanoparticles have been developed as inert systemic carriers for therapeutic compounds to target cells and tissues [33-38].”
• Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2) (2013, background): “Glycosaminoglycans are highly anionic, and interaction between proteoglycans and NP shells, if positively charged, tend to be largely ionic [25].”
• Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration (2010, background): “Due to their sizes being far greater or less than one hundred nanometers, the nanoparticulates are commonly used as gene delivery vehicles [134].”
• Engineered nanoparticles as precise drug delivery systems (2006, methodology): “Earlier reviews [Soppimath et al., 2001; Panyam and Labhasetwar, 2003] were dedicated to biodegradable nanoparticles preparation methods, drug loading, and their potential use in drug delivery systems.”